A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This clinical trial information was submitted voluntarily under the applicable law and,therefore, certain submission deadlines may not apply. (That is, clinical trialinformation for this applicable clinical trial was submitted under section 402(j)(4)(A)of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlinesestablished by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR11.24 and 11.44.).
Epistemonikos ID: 4b7248b4a1f26e01a70abee86c5051e04502b353
First added on: Aug 12, 2026